What's breaking now, across thousands of outlets.
Research released by the clinical AI company shows that its new dose verification tool outperformed general-use AI models, which it says are rife with errors. It’s Doximity’s latest play to stand out as major AI companies forge into healthcare.
We haven't written up this one. Healthcare Dive has the full story — the link below goes straight to it.
rained on 100 million square feet of building permits, dream wants to disrupt Autodesk with AI.
SuperMe just raised $20 million to let you pester AI clones of Silicon Valley’s savviest people about your career.
Africa’s AI builders must measure success by sector growth and incomes, not just products launched, the Gates Foundation told TechCabal’s Moonshot in Lagos.
The US economy grew at its fastest pace in a year in the third quarter, shrugging off higher oil prices stemming from the conflict in the Middle East as consumers maintained robust spending and…
Google's negative cash flow balloons to -$9.06 billion, and stock price tumbles following Q3 earnings.
Google owner admits ‘AI mode’ has hurt traditional search as sales and profits undershoot expectations
